Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (77)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kastenbauer, S.
Right arrow Articles by Pfister, H.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kastenbauer, S.
Right arrow Articles by Pfister, H.-W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 126, No. 5, 1015-1025, May 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg113

Pneumococcal meningitis in adults

Spectrum of complications and prognostic factors in a series of 87 cases

Stefan Kastenbauer and Hans-Walter Pfister

Department of Neurology, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany

Correspondence to: Stefan Kastenbauer, MD, Department of Neurology, Klinikum Grosshadern, Ludwig Maximilians University, Marchioninistrasse 15, 81377 Munich, Germany E-mail: stefan{at}kastenbauer.de

Studies on the incidence and spectrum of complications and prognostic factors in adults with pneumococcal meningitis are scarce. Therefore, we analysed 87 consecutive cases who were treated in our department between 1984 and 2002. Meningitis-associated intracranial complications developed in 74.7% and systemic complications in 37.9% of cases. Diffuse brain oedema (28.7%) and hydrocephalus (16.1%) developed more frequently than previously reported. The incidences of arterial (21.8%) and venous (9.2%) cerebrovascular complications were also very high. Furthermore, 9.2% of cases developed spontaneous intracranial haemorrhages (two patients with subarachnoid and two with subarachnoid and intracerebral bleedings, all in association with vasculitis; one subject with intracerebral haemorrhage due to sinus thrombosis; and three cases with intracerebral bleedings of unknown aetiology). Other new findings were the incidence of acute spinal cord dysfunction due to myelitis (2.3%) and that of hearing loss (19.5% of all patients and 25.8% of survivors). The in-hospital mortality was 24.1%. Only 48.3% of the patients had a good outcome at discharge [Glasgow Outcome Scale Score (GOS) = 5]. Outcome did not change during the study period, as mortality and GOS were similar for patients treated between 1984 and 1992 and for those treated between 1993 and 2002. Factors associated with a bad outcome (GOS <= 4) were chronic debilitating diseases, low Glasgow Coma Scale Score and focal neurological deficits on admission, low CSF leucocyte counts, pneumonia, bacteraemia and meningitis-associated intracranial and systemic complications. Low CSF leucocyte counts were also associated with the development of meningitis-associated intracranial complications. Age >=60 years was associated with a higher mortality (36.7 versus 17.5%), but the GOS of the survivors was comparable to that of the surviving younger patients. The causes of death were mostly systemic complications in the elderly and cerebral complications in the younger patients. A haematogenous pathogenesis seemed likely in asplenic patients, while contiguous spread from sinusitis or otitis was the major cause of meningitis in non-asplenic individuals. Furthermore, asplenic patients had a raised incidence of meningitis-associated intracranial complications, but their outcome was similar to that of non-asplenic subjects. The morbidity and mortality of pneumococcal meningitis in adults are still devastating. We report higher incidences (diffuse brain swelling, hydrocephalus, cerebrovascular complications) or new incidences (myelitis, hearing loss, subarachnoid bleeding) of intracranial complications. Our detailed analysis of prognostic factors may help clinicians to identify patients at risk and may also be helpful in the design of clinical trials.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
S. Ribes, S. Ebert, T. Regen, A. Agarwal, S. C. Tauber, D. Czesnik, A. Spreer, S. Bunkowski, H. Eiffert, U.-K. Hanisch, et al.
Toll-Like Receptor Stimulation Enhances Phagocytosis and Intracellular Killing of Nonencapsulated and Encapsulated Streptococcus pneumoniae by Murine Microglia
Infect. Immun., February 1, 2010; 78(2): 865 - 871.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. S. Schut, M. C. Brouwer, J. de Gans, S. Florquin, D. Troost, and D. van de Beek
Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis
Neurology, December 8, 2009; 73(23): 1988 - 1995.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. Steiner
Past as prologue: Delayed stroke as a parainfectious process of bacterial meningitis?
Neurology, December 8, 2009; 73(23): 1945 - 1946.
[Full Text] [PDF]


Home page
Therapeutic Advances in Neurological DisordersHome page
O. Hoffman and J. R. Weber
Review: Pathophysiology and treatment of bacterial meningitis
Therapeutic Advances in Neurological Disorders, November 1, 2009; 2(6): 401 - 412.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Paul, B. Obermaier, J. Van Ziffle, B. Angele, H.-W. Pfister, C. A. Lowell, and U. Koedel
Myeloid Src kinases regulate phagocytosis and oxidative burst in pneumococcal meningitis by activating NADPH oxidase
J. Leukoc. Biol., October 1, 2008; 84(4): 1141 - 1150.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al.
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke, September 1, 2008; 39(9): 2644 - 2691.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Zoons, M. Weisfelt, J. de Gans, L. Spanjaard, J. H.T.M. Koelman, J. B. Reitsma, and D. van de Beek
Seizures in adults with bacterial meningitis
Neurology, May 27, 2008; 70(22_Part_2): 2109 - 2115.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
N. Conlon, B. O'Brien, G. P. Herbison, and B. Marsh
Long-term functional outcome and performance status after intensive care unit re-admission: a prospective survey
Br. J. Anaesth., February 1, 2008; 100(2): 219 - 223.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. R. Keane
Bilateral Ocular Paralysis: Analysis of 31 Inpatients
Arch Neurol, February 1, 2007; 64(2): 178 - 180.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. T. Brandt, N. Frimodt-Moller, J. D. Lundgren, M. Pedersen, I. C. Skovsted, I. J. Rowland, and C. Ostergaard
Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis
J. Antimicrob. Chemother., December 1, 2006; 58(6): 1291 - 1294.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
U. Malipiero, U. Koedel, H.-W. Pfister, P. Leveen, K. Burki, W. Reith, and A. Fontana
TGF{beta} receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis
Brain, September 1, 2006; 129(9): 2404 - 2415.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. N. Meli, R. S. Coimbra, D. G. Erhart, G. Loquet, C. L. Bellac, M. G. Tauber, U. Neumann, and S. L. Leib
Doxycycline Reduces Mortality and Injury to the Brain and Cochlea in Experimental Pneumococcal Meningitis
Infect. Immun., July 1, 2006; 74(7): 3890 - 3896.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. van de Beek, J. de Gans, A. R. Tunkel, and E. F.M. Wijdicks
Community-Acquired Bacterial Meningitis in Adults
N. Engl. J. Med., January 5, 2006; 354(1): 44 - 53.
[Full Text] [PDF]


Home page
BrainHome page
G. Sebire, B. Tabarki, D. E. Saunders, I. Leroy, R. Liesner, C. Saint-Martin, B. Husson, A. N. Williams, A. Wade, and F. J. Kirkham
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome
Brain, March 1, 2005; 128(3): 477 - 489.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. A. Samuels
Update in Neurology
Ann Intern Med, January 4, 2005; 142(1): 28 - 36.
[Full Text] [PDF]


Home page
NEJMHome page
D. van de Beek, J. de Gans, L. Spanjaard, M. Weisfelt, J. B. Reitsma, and M. Vermeulen
Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis
N. Engl. J. Med., October 28, 2004; 351(18): 1849 - 1859.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
U. Koedel, T. Rupprecht, B. Angele, J. Heesemann, H. Wagner, H.-W. Pfister, and C. J. Kirschning
MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS
Brain, June 1, 2004; 127(6): 1437 - 1445.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L Ginsberg
DIFFICULT AND RECURRENT MENINGITIS
J. Neurol. Neurosurg. Psychiatry, March 1, 2004; 75(90001): i16 - 21.
[Full Text] [PDF]


Home page
JWatch NeurologyHome page
Complications of Pneumococcal Meningitis in Adults
Journal Watch Neurology, July 11, 2003; 2003(711): 8 - 8.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.